Search

everythinglearnresearchcommunity

for

Search:↓

FGF9 controls which receptors it binds to through a process where two FGF9 molecules join, and changes in FGF9 can lead to incorrect receptor activation.

Hair follicle regeneration may slow tumor growth.

Multiphoton microscopy can effectively assess breast cancer treatment responses without labels.

Hair loss in women can be slowed with treatment, but more research needed for better solutions.

Sleep, testosterone levels, and a specific enzyme activity affect skin oil production in women.

Finasteride treatment changes urine metabolomics and steroid signatures, potentially monitoring effectiveness but may cause sexual side effects.

Adding cells to fat grafts improves hair regrowth in early baldness, but effects lessen over time.

Platelet-rich fibrin shows promise for treating oral lesions but needs more research.

Low-dose radiation therapy may improve brain function in some Alzheimer's patients and is generally well-tolerated.

Activating β-catenin in mammary cells leads to changes that cause early-stage abnormal growths similar to skin structures.

PRF and CGF are becoming more popular than PRP in regenerative medicine due to their simplicity and lack of additives.

The skin can still regenerate and function well even with fewer fibroblasts.

Blocking glucocorticoid receptors improves glucose metabolism in a PCOS mouse model.

Microplastics in the Lebanese Mediterranean carry harmful pollutants, posing environmental and health risks.

Fibroblast growth factor receptor signaling controls cell development and repair, and its malfunction can cause disorders and cancer, but it also offers potential for targeted therapies.

Human skin makes sexual hormones that affect hair growth, skin health, and healing; too much can cause acne and hair loss, while treatments can manage these conditions.

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

Understanding phenotypic plasticity is crucial for developing effective cancer therapies.

Dehydroepiandrosterone (DHEA) is a prohormone important for producing sex steroids and has potential health benefits.

Hair growth phase and certain genes can speed up wound healing, while an inflammatory mediator can slow down new hair growth after a wound. Understanding these factors can improve tissue regeneration during wound healing.

The document concludes that understanding hair follicle biology can lead to better hair loss treatments.

TNF alpha in skin cells causes weight loss, hair and fat issues, and skin inflammation in mice.

Transplant success has improved with better immunosuppressive drugs and donor matching.

Estrogen replacement can improve skin health in menopausal women but doesn't reverse sun damage or prevent hair loss.

The conclusion is that PCOS is caused by ovarian sensitivity to hormones and disrupted hormone control, possibly due to ovarian factors, and more research is needed.

Different types of stem cells exist within individual skin layers, and they can adapt to damage, transplantation, or tumor growth. These cells are regulated by their environment and genetic factors. Tumor growth is driven by expanding, genetically altered cells, not long-lived mutant stem cells. There's evidence of cancer stem cells in skin tumors. Other cells, bacteria, and genetic factors help maintain balance and contribute to disease progression. A method for growing mini organs from single cells has been developed.

The document concludes that understanding hair structure is key to diagnosing hair abnormalities and recommends gentle hair care for management.

Mesenchymal stem cells are key to future tissue regeneration in oral surgery.

Adult female acne treatment should be personalized, considering individual preferences and pregnancy, using various topical and oral medications while managing side effects and resistance.